Nutritional support for liver disease

Cochrane Database of Systematic Reviews

Volumn 2012, Issue 5, 2012, Pages

  Koretz, Ronald L ^a   Avenell, Alison ^b   Lipman, Timothy O ^c  

^a Granada Hills Charter High School   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Department of Veterans AHairs Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCITES; ENTERIC FEEDING; HEPATIC ENCEPHALOPATHY; HUMAN; INFECTION; LIVER DISEASE; META ANALYSIS; METHODOLOGY; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

ASCITES; ENTERAL NUTRITION; HEPATIC ENCEPHALOPATHY; HUMANS; INFECTION; LIVER DISEASES; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84864660514     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008344.pub2     Document Type: Review

References (354)

1. Achord JL. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis. American Journal of Gastroenterology 1987;829:871-5.
2. Bonkovsky H, Fiellin D, Smith G, Slaker D, Simon D, Galambos J. Treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone: A randomized controlled trial I short-term effects on liver function AASLD abstract. Hepatology 1990;124:870.
3. Bonkovsky H, Jafri I, Singh R, Cotsonis G, Slaker D. Treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone: A randomized controlled trial II Effects on nitrogen metabolism AASLD abstract. Hepatology 1990;124:978.
4. Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone I Short-term effects on liver function. American Journal of Gastroenterology 1991;869:1200-8.
5. Bonkovsky HL, Singh RH, Jafri IH, Fiellin DA, Smith GS, Simon D, et al. A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone II Short-term effects on nitrogen metabolism, metabolic balance, and nutrition. American Journal of Gastroenterology 1991;869:1209-18.
6. Bunout D, Aicardi V, Hirsch S, Petermann M, Kelly M, Silva G, et al. Nutritional support in hospitalized patients with alcoholic liver disease. European Journal of Clinical Nutrition 1989;439:615-21.
7. Abad-Lacruz A, Cabre E, Gonzalez-Huix F, Esteve M, Xiol X, Acero D, et al. Total enteral nutrition TEN as a new approach influencing the clinical outcome and mortality in liver cirrhosis LC AASLD abstract. Hepatology 1988;85:1413.
8. Cabre E, Abad A, Glez-Huix F, Esteve M, Xiol X, Acero D, et al. Total enteral nutrition as a new approach influencing the clinical outcome and mortality in liver cirrhosis abstract. Journal of Parenteral and Enteral Nutrition 1989;13 Suppl1:10.
9. Cabre E, Gonzales-Huix F, Abad-Lacruz A, Esteve M, Xiol X, Acero D, et al. Effect of total enteral nutrition TEN on the clinical outcome of hospitalized cirrhotics with severe protein- energy malnutrition PEM abstract. Clinical Nephrology 1988;7 Special Suppl:34.
10. Cabre E, Gonzalez Huix F, Abad Lacruz A, Esteve M, Acero D, Fernandez Banares F, et al. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics A randomized controlled trial. Gastroenterology 1990;983:715-20.
11. Calvey H, Davis M, Williams R. Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis. Journal of Hepatology 1985;12:141-51.
12. Calvey H, Davis M, Williams R. Prospective study of nasogastric feeding via East Grinstead Reg.trademark or Viomedex Reg.trademark tubes compared with oral dietary supplementation in patients with cirrhosis. Clinical Nutrition 1984;32:63-6.
13. Williams R, Calvey H, Davis M. Controlled trial of nutritional supplementation in acute alcoholic hepatitis. In: Holm E, Kasper H editors. Metabolism and nutrition in liver disease. Lancaster, England: MTP Press, Ltd., 1985:361-8.
14. De Ledinghen V, Mannant PR, Beau P, Borderie C, Oui B, Silvain C, et al. Effects of early enteral nutrition in cirrhotics patients after bleeding from esophageal varices: A randomized controlled study Abstract. Gastroenterology 1996;1104:A13.
15. de Ledinghen V, Beau P, Mannant PR, Borderie C, Ripault MP, Silvain C, et al. Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study. Digestive Diseases and Sciences 1997;423:536-41.
16. de Ledinghen V, Mannant PR, Beau P, Borderie C, Ripault MP, Silvain C, et al. Effect of enteral nutrition immediately after digestive hemorrhage in cirrhotics: A randomised controlled study abstract Effets de la nutrition enterale au decours immediat de l’ hemorragie digestive du cirrhotique: Etude controlee randomisee abstract. Gastroenterologie Clinique et Biologique 1996;20 Suppl:A120.
17. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. New England Journal of Medicine 1994;33123:1547-52.
18. Foschi D, Cavagna G, Callioni F, Morandi E, Rovati V. Hyperalimentation of jaundiced patients on percutaneous transhepatic biliary drainage. British Journal of Surgery 1986;739:716-9.
19. Guy S, Tanzer-Torres G, Palese M, Sheiner P, Mor E, Emre S, et al. Does nasoenteral nutritional support reduce mortality after liver transplant? Abstract. Hepatology 1995;22:144A.
20. Hasse JM, Blue LS, Liepa GU, Goldstein RM, Jennings LW, Mor E, et al. Early enteral nutrition support in patients undergoing liver transplantation. Journal of Parenteral and Enteral Nutrition 1995;196:437-43.
21. Hasse J, Crippin J, Blue L, Huang K, DiCecco S, Francisco- Ziller N, et al. Does nutrition supplementation benefit liver transplant candidates with a history of encephalopathy? Abstract. Journal of Parenteral and Enteral Nutrition 1997;211:S16.
22. Hayashi S, Aoyagi Y, Fujiwara K, Oka H, Oda T. A randomized controlled trial of branched-chain amino acid BCAA-enriched elemental diet ED-H for hepatic encephalopathy abstract. Journal of Gastroenterology and Hepatology 1991;62:191.
23. Hayashi S, Aoyagi Y, Oka H, Oda T. A randomized controlled study of an elementary diet ED-H in cirrhotics with hepatic encephalopathy. Unpublished data.
24. Hendry PO, Van Dam RM, Bukkems SFFW, McKeovm DW, Parks RW, Preston T, et al. Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. British Journal of Surgery 2010;978:1198-206.
25. Hirsch S, Bunout D, de la Maza P, Iturriaga H, Petermann M, Icazar G, et al. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. Journal of Parenteral and Enteral Nutrition 1993;172:119-24.
26. Humbert P, Pintó A, Johnston S, Fábrega C, Planas R, Boix J, et al. Effect of oral administration of branched-chain amino acids for the treatment of nutrition disturbances and for the prophylaxis of encephalopathy in cirrhotic patients Efecto de la administración oral de aminoácidos ramificados en el tratamiento de los trastornos nutricionales y en la prevención de la encefalopatía de pacientes cirróticos.. Gastroenterología y Hepatología 1989;121:9-13.
27. Ichikawa T, Naota T, Miyaaki H, Miuma S, Isomoto H, Takeshima F, et al. Effect of an oral branched chain amino acid- enriched snack in cirrhotic patients with sleep disturbance. Hepatology Research 2010;4010 Oct:971-8.
28. Ishikawa Y, Yoshida H, Mamada Y, Taniai N, Matsumoto S, Bando K, et al. Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery. Hepatogastroenterology 2010;57:583-90.
29. Ishikawa Y, Yoshida H, Weiner J, Tajiri T. Prospective randomized controlled study of short-term perioperative enteral nutrition support with branched chain amino acids in liver surgery Abstract. Gastroenterology 2009;136 Suppl 1:176.
30. Kearns PJ, Young H, Garcia G, Blaschke T, O’Hanlon G, Rinki M, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992;1021:200-5.
31. Kobashi H, Morimoto Y, Ito T, Shimoe T, Makino Y, Araki Y, et al. Effects of supplementation with a branched-chain amino acid- enriched preparation on event-free survival and quality of life in cirrhotic patients with hepatocellular carcinoma. A multicenter, randomized controlled trial Abstract. Gastroenterology 2006;130:A497.
32. LeCornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation 2000;697:1364-9.
33. Meng WC, Leung KL, Ho RL, Leung TW, Lau WY. Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma. Australian and New Zealand Journal of Surgery 1999;6911:811-5.
34. Mikagi K, Kawahara R, Kinoshita H, Aoyagi S. Effect of preoperative immunonutrition in patients undergoing hepatectomy; a randomized controlled trial. Kurume Medical Journal 2011;581:1-8.
35. Nakaya Y, Ikita K, Suzuki K, Moriwaki H, Kato A, Miwa Y, et al. BCAA-enriched snack improves nutritional state of cirrhosis.. Nutrition 2007;23:113-20.
36. Nakaya Y, Okita K, Kato A, Miwa Y, Suzuki K, Moriwaki H. Randomized trial of branched chain amino acid rich supplement against carbohydrate-rich snacks as a late evening snack in patients with liver cirrhosis Abstract. Hepatology 2005;42 Suppl 14:699A-700A.
37. Naveau S, Pelletier G, Poynard T, Attali P, Poitrine A. Buffet C, et al. A randomised Clinical trial of supplementary parenteral nutrition in jaundiced alcoholic cirrhotic patients. Hepatology 1986;62:270-4.
38. Norman K, Kirchner H, Friedrich U, Lochs H, Ockenga J, Pirlich M. Enteral nutrition improves functional parameters in patients with advanced liver cirrhosis Abstract Enterale Ernahrung verbessert funktionale Parameter in Patienten mit fortgeschrittener Leberzirrhose. Zeitschrift fur Gastroenterologie 2005;438:913.
39. Norman K, Smoliner C, Stobacus N, Schuetz T, Lochs H, Ockenga, et al. Early enteral nutrition improves functional parameters in liver cirrhosis Abstract. Gastroenterology 2008;134 Suppl 1:A563.
40. Pirlich M, Norman K, Lochs H. Malnutrition in liver cirrhosis: Impact of protein rich oral diet. Zeitschrift fur Gastroenterologie 2006;444:344-5. MEDLINE: 16625465
41. Poon RT, Yu WC, Fan ST, Wong J. Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: A randomized trial. Alimentary Pharmacology and Therapeutics 2004;197:779-88.
42. Ceriati F, Cavicchioni C, Marino IR, De Luca G, Puglionisi A. Management of hepatic encephalopathy in cirrhotic patients after derivative surgery Trattamento dell’encefalopatia epatica nei pazienti cirrotici sottoposti ad intervento chirurgico derivativo. Acta Medica Romana 1985;231:69-76.
43. Puglionisi A, Ceriati F, Marino IR, Cavicchioni C, De Luca G, Roncone A, et al. Prophylaxis of hepatic encephalopathy after porta-caval anastomosis using branched chain amino acid mixtures. In: Capacaccio L, Fischer JE, Rossi-Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:345-50.
44. Qiu Y, Zhu X, Wang W, Xu Q, Ding Y. Nutrition support with glutamine dipeptide in patients undergoing liver transplantation. Transplantation Proceedings 2009;41:4232-7.
45. Reilly J, Mehta R, Teperman L, Cemaj S, Tzakis A, Yanaga K, et al. Nutritional support after liver transplantation: A randomized prospective study. Journal of Parenteral and Enteral Nutrition 1990;144:386-91.
46. Reilly J, Yanaga K, Tzakis A, Teperman L, Mehta R, Rezak A, et al. A randomized prospective study of nutritional support after liver transplant Abstract. Journal Parenteral and Enteral Nutrition 1989;13:8S.
47. Heys SD. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: A prospective randomized trial Letter. British Journal of Surgery 1998;853:423.
48. Mann DV. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: A prospective randomized trial Letter. British Journal of Surgery 1998;856:875.
49. Nagasue N. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: A prospective randomized trial-reply. British Journal of Surgery 1998;853:423-4.
50. San-in Group of Liver Surgery. Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: A prospective randomized trial. British Journal of Surgery 1997;8411:1525-31.
51. Schuetz T, Norman K, Friedrich-Pagels U, Ockenga J, Luu TN, Lochs H, et al. Tube feeding does not affect subclinical hepatic encephalopathy in patients with liver cirrhosis Abstract. Gastroenterology 2006;130:A326.
52. Stevert W, Gibson PR, Colman JC, Kronborg I, Crawford DH, Keogh J, et al. Energy and amino acid supplements in malnourished patients with cirrhosis: A randomised controlled trial Abstract. Hepatology 1999;30:434A.
53. Simko V. Long-term tolerance of a special amino acid oral formula in patients with advanced liver disease. Nutrition Reports International 1983;274:765-73.
54. Galambos JT, Simon D. Peripheral hyperalimentation Ppn in moderate and severe alcoholic hepatitis Ah-a randomized controlled-study abstract. Alcohol and Alcoholism 1988;233:A25.
55. Simon D, Galambos JT. A randomized controlled study of peripheral parenteral nutrition in moderate and severe alcoholic hepatitis. Journal of Hepatology 1988;72:200-7.
56. Simon D, Galambos JT. Peripheral hyperalimentation Ppn in moderate and severe alcoholic hepatitis Ah: A randomized controlled study Abstract. Hepatology 1986;65:1163.
57. Simon D, Galambos JT. Peripheral hyperalimentation Ppn in severe alcoholic hepatitis Ah-a blinded randomized controlled study-preliminary data abstract. Digestive Diseases and Sciences 1986;3110:S216.
58. Simon DM, Galambos JT. Peripheral hyperalimentation Ppn in moderate and severe alcoholic hepatitis Ah a randomized controlled study abstract. American Journal of Gastroenterology 1987;829:979.
59. Takeshita S, Ichikawa T, Nakao K, Miyaaki H, Shibata H, Matsuzaki T, et al. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma. Nutrition Research 2009;29:89-93.
60. Tangkijvanich P, Mahachai V, Wittayalertpanya S, Ariyawongsopon V, Isarasena S. Short-term effects of branched- chain amino acids on liver function tests in cirrhotic patients. The Southeast Asian Journal of Tropical Medicine and Public Health 2000;311:152-7.
61. Hu Q-G, Zheng Q-C. The influence of enteral nutrition in postoperative patients with poor liver function. World Journal of Gastroenterology 2003;94:843-6.
62. Zheng Q, Hu Q. The influence of enteral nutrition on gut barrier in the post-operative patients with damaged hepatic function. Journal of Tongji Medical University 2001;214:323-5.
63. Abad Lacruz A, Gonzalez Huix F, Esteve M, Fernandez Banares F, Cabre E, Boix J, et al. Liver function tests LFT derangement in patients with active inflammatory bowel disease IBD on either ten or TPN A prospective, randomized study Abstract. Clinical Nutrition 1988;7 Special Suppl:60.
64. Abad Lacruz A, Gonzalez Huix F, Esteve M, Fernandez Banares F, Cabre E, Boix J, et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: A prospective randomized study of total enteral nutrition vs total parenteral nutrition. Journal of Parenteral and Enteral Nutrition 1990;146:618-21.
65. Adams L, Zhu K, Kerr D, Devine A, Solah V.A, Binns C, et al. The effect of whey protein supplementation on hepatic steatosis: Results from a randomized placebo controlled trial in postmenopausal women abstract. Hepatology 2011;54 Suppl 1:1146A.
66. Akoglu B, Schrott M, Bolouri H, Jaffari A, Kutschera E, Caspary WF, et al. The folic acid metabolite L-5- methyltetra hyd rofolate effectively reduces tota l serum homocysteine level in orthotopic liver transplant recipients: A double-blind placebo-controlled study. European Journal of Clinical Nutrition 2008;626:796-801.
67. Al Mardini H, Douglass A, Record CA. Amino acid challenge in patients with cirrhosis and control subjects: Ammonia, plasma amino acid and EEG changes. Metabolic Brain Disease 2006;211:1-10.
68. Alvarez MA, Cabre E, Lorenzo-Zuniga V, Montoliu S, Planas R, Gassull MA. Combining steroids with enteral nutrition: A better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study. European Journal of Gastroenterology and Hepatology 2004;1612:1375-80.
69. Andreone P, Fiorino S, Cursaro C, Gramenzi A, Margotti M, Di Giammarino L, et al. Vitamin E as treatment for chronic hepatitis B: Results of a randomized controlled pilot trial. Antiviral Research 2001;492:75-81.
70. Awad S, Constantin-Teodosiu D, Constantin D, Rowlands BJ, Fearon KCH, Macdonald IA, et al. Cellular mechanisms underlying the protective effects of preoperative feeding. Annals of Surgery 2010;252:247-53.
71. Badalamenti S, Salerno F, Lorenzano E, Paone G, Como G, Finazzi S, et al. Renal effects of dietary supplementation with fish oil in cyclosporine- treated liver transplant recipients. Hepatology 1995;226:1695-701.
72. Baldermann H, Wicklmayr M, Rett K, Banholzer P, Dietze G, Mehnert H. Changes in ultrasonic findings in the liver in relation to parenteral nutrition with long chain triglyceride and medium chain triglyceride/long chain triglyceride lipid solutions Untersuchungen zur Veranderung des Sonographiebefundes der Leber unter parenteraler Ernahrung mit LCT-bzw MCT/LCT Lipidlosungen. Infusionstherapie 1988;154:140-3.
73. Baldermann H, Wicklmayr M, Rett K, Banholzer P, Dietze G, Mehnert H. Changes of hepatic morphology during parenteral nutrition with lipid emulsions containing LCT or MCT/LCT quantified by ultrasound. Journal of Parenteral and Enteral Nutrition 1991;156:601-3.
74. Barle H, Nyberg B, Andersson K, Essen P, McNurlan MA, Wernerman J, et al. The effects of short-term parenteral nutrition on human liver protein and amino acid metabolism during laparoscopic surgery. Journal of Parenteral and Enteral Nutrition 1997;216:330-5.
75. Bartels M, Biesalski HK, Engelhart K, Sendlhofer G, Rehak P, Nagel E. Pilot study on the effect of parenteral vitamin E on ischemia and reperfusion induced liver injury: A double blind, randomized, placebo-controlled trial. Clinical Nutrition 2004;236:1360-70.
76. Bernardi R. Liver, protein metabolism, branched chain amino acids Fegato, metabolismo proteico, aminoacidi a catena ramificata. La Clinica Terapeutica 1981;99:653-75.
77. Bianchi G.P, Marchesini G, Fabbri A, Rondelli A, Bugianesi E, Zoli M, et al. Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. Journal of Internal Medicine 1993;2335:385-92.
78. Bories PN, Campillo B. One-month regular oral nutrition in alcoholic cirrhotic-patients-changes of nutritional-status, hepatic-function and serum-lipid pattern. British Journal of Nutrition 1994;726:937-46.
79. Brans YW, Ritter DA, Kenny JD, Andrew DS, Dutton EB, Carrillo DW. Influence of intravenous fat emulsion on serum bilirubin in very low birthweight neonates. Archives of Disease in Childhood 1987;622:156-60.
80. Bresci G, Parisi G, Banti S. Management of hepatic encephalopathy with oral zinc supplementation: A long-term treatment. European Journal of Medicine 1993;27:414-6.
81. Buchmiller CE, Kleiman-Wexler RL, Ephgrave KS, Booth B, Hensley CE. Liver dysfunction and energy source: results of a randomized clinical trial. Journal of Parenteral and Enteral Nutrition 1993;174:301-6.
82. Cabre E. Outcome of severe alcoholic hepatitis SAH treated with steroids STE or total enteral nutrition TEN Abstract. Journal of Hepatology 2000;322:32.
83. Cabre E. Short and long-term outcome in severe alcoholic hepatitis SAH treated with steroids or total enteral nutrition TEN Abstract. Hepatology 1999;304:405A.
84. Cabre E. Short and long-term outcome in severe alcoholic hepatitis SAH treated with steroids or total enteral nutrition TEN. A multicentric randomized controlled trial Abstract. Hepatology 1999;304:979.
85. Cabre E. Treatment of severe alcoholic hepatitis with steroids or total enteral nutrition: Interim results of a prospective, randomized, multicentric trial. Gastroenterology 1998;1144:G3562.
86. Cabre E. Treatment of severe alcoholic hepatitis with steroids or total enteral nutrition: Interim results of a prospective, randomized, multicentric trial Abstract. Clinical Nephrology 1998;17 Suppl 1:18.
87. Cabre E, Rodriguez Iglesias P, Caballeria J, Quer JC, Sanchez Lombrana JL, Pares A, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial. Hepatology 2000;321:36-42.
88. Cabre E, Rodriguez-Iglesias P, Caballeria J, Quer JC, Sanchez- Lombrana JL, Pares A, et al. Short- and long-term outcome of sever alcohol-induced hepatitis treated with steroids or enteral nutrition: A multicenter randomized trial abstract. European Journal of Gastroenterology and Hepatology 2000;128:963-6.
89. Cabre E, Spanish Group for the Study of Alcoholic Hepatitis. Steroids vs enteral nutrition in severe alcoholic hepatitis Interim results of a prospective, randomized, multicentric trial Abstract. Journal of Hepatology 1998;28 Suppl 11:129.
90. Gassull M, Cabre E. Short and long-term outcome in severe alcoholic hepatitis SAH treated with steroids or total enteral nutrition TEN. A multicentric randomized controlled trial by the Spanish Group for the study of Alcoholic Hepatitis. Journal of Parenteral and Enteral Nutrition 2000;241:S5.
91. Campo G, Amodio P, Caregaro L, Sacerdoti D, Bolognesi M, Burlina A, et al. Effect of a dietary integration with BCAA or casein on nutritional state and lower limb amino acid exchange in cirrhosis. Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Great Britain: Ipswich Book Company Ltd., 1997:149-55.
92. Cao J, Luo SM, Liang L, Lai J. Effects of parenteral nutrition without and with growth hormone on growth hormone/insulin¬like growth factor-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis. Journal of Parenteral and Enteral Nutrition 2007;316:496-501.
93. Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, et al. A multicenter trial of branched chain enriched amino acid infusion F080 in hepatic encephalopathy HE Abstract. Hepatology 1982;25:699.
94. Cerra FB, McMillen M, Angelico R, Cline B, Lyons J, Faulkenbach L, et al. Cirrhosis, encephalopathy, and improved results with metabolic support. Surgery 1983;944:612-9.
95. Cerra FB, Cheung NK, Fischer JE, Kaplowitz N, Schiff ER, Dienstag JL, et al. Disease-specific amino acid infusion F080 in hepatic encephalopathy: A prospective, randomized, double-blind, controlled trial. Journal of Parenteral and Enteral Nutrition 1985;93:288-95.
96. Cowan GS Jr. Disease-specific amino acid infusion F080 in hepatic encephalopathy: A prospective, randomized, double¬blind, controlled trial Letter. Journal of Parenteral and Enteral Nutrition 1986;10:247.
97. Cerwenka H, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F, Hauser H, et al. Antioxidant treatment during liver resection for alleviation of ischemia-reperfusion injury. Hepato-Gastroenterology 1998;4521:777-82.
98. Chelarescu O, Chelarescu D, Rusu M, Stratan I. Parenteral vs enteral nutrition in acute liver failure Abstract. Journal of Hepatology 2003;38 Suppl 2:192
99. Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA, et al. Nutritional support in children with end-stage liver disease: A randomized crossover trial of a branched-chain amino acid supplement. American Journal of Clinical Nutrition 1992;561:158-63.
100. Christie ML, Sack DM, Horst D, Lenger S, Pomposelli J. Enriched branched-chain amino acid formula versus a casein based supplement in the treatment of cirrhosis Abstract. Journal of Parenteral and Enteral Nutrition 1984;8:91.
101. Christie ML, Sack DM, Pomposelli J, Horst D. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. Journal of Parenteral and Enteral Nutrition 1985;96:671-8.
102. Clarke S, Bernal W, Rees G, Wendon J. Immunonutrition in critically ill patients with liver disease: A prospective randomised double-blind controlled trial. Hepatology 2004;40 Suppl 1:500A.
103. Conti F, Natangelo R, Cattani F, Mandelli V. Controlled clinical trial of liver-protective agents La sperimentazione clinica controllata degli epatoprotettori. La Clinica Terapeutica 1971;592:155-65.
104. Córdobo J. Effects of proteins in patients with cirrhosis and prior hepatic encephalopathy. ClinicalTrials.gov 2009. Other ClinicalTrials.gov: NCT00955500
105. Cordoba J, Sanpedro F, Lopez-Hellin Sabin P, Planas M, Esteban R, Guardia J. A low-protein diet does not improve the outcome of acute hepatic encephalopathy. Results of a pilot study using enteral nutrition Abstract. Hepatology 2001;344:187A.
106. Córdoba J, López-Hellín J, Planas M, Sabín P, Sanpedro F, Castro F, et al. Normal protein diet for episodic hepatic encephalopathy: Results of a randomized study. Journal of Hepatology 2004;411:38-43.
107. Cortez Pinto H, Cravo M, Saraiva A, Camilo ME, Moura MC. Parenteral nutrition in cirrhosis Abstract. Journal of Hepatology 1990;10 Suppl 1:19.
108. Cunha L, Nono MH, Guibert AL, Nidegger D, Beau P, Beauchant M. Effects of prolonged oral nutritional support in malnourished cirrhotic patients: Results of a pilot study. Gastroenterologie Clinique Et Biologique 2004;281:36-9.
109. De Antoni E, Grilli P, Orsi E.. Efficacy of TPN in cirrhotic patients with bleeding esophageal varices. Italian Journal of Surgical Sciences 1984;143:253-5.
110. De-Fang Z, Ke Z, Ren L, Li-Jun Z. Clinical observation of enteral immunonutrition in patients undergoing liver transplantation. Journal of Clinical Rehabilitative Tissue Engineering Research 2011;1531:5873-8.
111. de la Maza MP, Petermann M, Bunout D, Hirsch S. Effects of long¬term vitamin E supplementation in alcoholic cirrhotics. Journal of the American College of Nutrition 1995;142:192-6.
112. de Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde RTI. Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. Nutricion Hospitalaria 2010;255:730-5.
113. Di Cecco SR, Francisco-Ziller NM, Porayko MK, Crippin JS, Blue LS, Huang KS, et al. Does pretransplant oral nutrition supplementation affect post-transplant clinical outcomes? Abstract. Hepatology 1997;264 Pt 2:500A.
114. Diehl AM, Boitnott JK, Herlong HF, Potter JJ, Van Duyn MA, Chandler E, et al. Effect of parenteral amino acid supplementation in alcoholic hepatitis. Hepatology 1985;51:57-63.
115. Dionigi P, Holdsworth JD, Clague MB, James OF, Wright PD. Body protein synthesis and breakdown in chronic liver disease. The effect of different amino acid solutions Abstract. Clinical Nutrition 1984;2 Special Suppl:O.81.
116. Egberts E-H, Hamster W, Jurgens P, Schumacher H, Fondalinski G, Reinhard U, et al. Effect of branched chain amino acids on latent portal-systemic encephalopathy. In: Walser M, Williamson JR editors. Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Amsterdam: Elsevier North Holland, 1981:453-63.
117. Hamster W, Egberts EH, Hamster H. Treatment with branched- chain amino acids and effect on psycho-physical capacity functions in latent porto-systemic encephalopathy Behandlung mit verzweigtkettigen aminosauren und ihre auswirkung auf psychophysische leistungsfunktionen bel latenter portosystemischer enzephalopathie. Arzneimittelforschung 1982;32:901-2.
118. Egberts EH, Hamster W, Schomerus H, Jürgens P. Effect of branched chain amino acids on latent porto-systemic- encephalopathy PSE Abstract. Journal of Parenteral and Enteral Nutrition 1981;5:354.
119. Egberts EH, Schomeerus H, Hamster W, Jürgens P. Effective treatment of latens porto-systemic encephalopathy with oral branched chain amino acids. In: Capocaccia L, Fischer JE, Rossi- Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. Plenum Press, New York, 1984:351-7
120. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched chain amino acids in the treatment of latent portosystemic encephalopathy A double-blind placebo-controlled crossover study. Gastroenterology 1985;884:887-95.
121. Egberts EH, Schomerus H, Hamster W, Jurgens P. Branched- chain amino acids in the treatment of latent porto-systemic encephalopathy A placebo-controlled double-blind cross-over study Verzweigtkettige Aminosauren bei der Behandlung der latenten portosystemischen Enzephalopathie Eine placebokontrollierte Doppelblind-Cross-over-Studie. Zeitschrift für Ernährungswissenschaft 1986;251:9-28.
122. Egberts E-H, Plauth M, Hamster W, Torok M, Brand O, Furst P. Long-term double-blind crossover study on the treatment of latent portosystemic encephalopathy PSE with branched chain amino acids BCAA Abstract. Clinical Nutrition 1988;76 Suppl:31.
123. Eriksson LS, Persson A, Wahren J. Branched-chain amino acids in the treatment of chronic hepatic encephalopathy. Gut 1982;2310:801-6.
124. Eriksson LS, Persson A, Wahren J. Failure of oral branched- chain amino acids to improve chronic hepatic encephalopathy Abstract. Journal of Parenteral and Enteral Nutrition 1981;5:355.
125. Ferenci P, Dragosics B, Wewalka F. Oral administration of branched chain amino acids BCAA and keto acids BCKA in patients with liver cirrhosis LC. In: Walser M, Williamson JR editors. Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Amsterdam: Elsevier North Holland, 1981:507-12.
126. Fiaccadori F, Ghinelli F, Pedretti G, Pelosi G, Sacchini D, Zeneroli ML, et al. Branched chain amino acid enriched solutions in the treatment of hepatic encephalopathy: A controlled trial. In: Capocaccia L, Fischer JE, Rossi-Fanelli F editors. Hepatic encephalopathy in chronic liver failure. Plenum Press, New York, 1984:323-33.
127. Fiaccadori F, Ghinelli F, Pedretti G, Pelosi G, Sacchini D, Zeneroli ML, et al. Branched-chain enriched amino acid solutions in the treatment of hepatic encephalopathy: A controlled trial Abstract. Italian Journal of Gastroenterology 1985;17:5-10.
128. Fiaccadori F, Ghinelli F, Pelosi G, Sacchini D, Vaona GL, Zeneroli ML, et al. Selective amino acid solutions in hepatic encephalopathy a preliminary report. La Ricerca in Clinica e in Laboratorio 1980;10:411-22.
129. Fiaccadori F, Elia GF, Lehndorff H, Merli M, Pedretti G, Riggio O, et al. The Effect of dietary supplementation with branched- chain amino acids BCAAsvs casein in patients with chronic recurrent portal systemic encephalopathy: A controlled trial. In: Soeters PB, Wilson JHP, Meijer AJ, Holm E editors. Advances in Ammonia Metabolism and Hepatic Encephalopathy. Amsterdam: Elsevier Science Publishers B.V., 1988:489-97.
130. Fiaccadori F, Lehndorff H, Merli M, Pedretti G, Perinotto P, Riggio O, et al. BCAA oral dietary supplementation vs casein in chronic recurrent HE A controlled trial Abstract. Journal of Hepatology 1987;4 Suppl 1:16.
131. Freeman JG, Bassendine M, Heath P, James OFW, Record CO. Double blind trial of branched chain amino acid infusions in cases of hepatic encephalopathy Abstract. Gut 1983;245:A503.
132. Fukushima H, Miwa Y, Ida E, Kuriyama S, Toda K, Shimomura Y, et al. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: Comparison with daytime administration. Journal Parenteral Enteral Nutrition 2003;275:315-22. MEDLINE: 12971730
133. Galloway JR, Hooks MA, Millikan WJ, Henderson JM, Towns M, Kutner MH, et al. The nutritional effects of F080 versus standard intravenous hyperalimentation in malnourished cirrhotics with subclinical encephalopathy Abstract. Journal of Parenteral and Enteral Nutrition 1987;13 Suppl 1:8.
134. Gavazzl C, Bozzetti F, Crippa F, Mariani L, Antonini R. Impact of different energy substrates on liver metastases metabolism Abstract. Clinical Nutrition 1999;18 Suppl 1:50.
135. Glynn MJ, Powell Tuck J, Reaveley DA, Murray Lyon IM. High lipid parenteral nutrition improves portosystemic encephalopathy. Journal of Parenteral and Enteral Nutrition 1988;125:457-61.
136. Glynn MJ, Powell-Tuck J, Reaveley D, Murray-Lyon IM. High lipid parenteral feeds raise plasma branched chain amino acid concentrations-a possible therapeutic approach to portasystemic encephalopathy? Abstract. Gut 1985;265:A569.
137. Glynn MJ, Powell-Tuck J, Reaveley DA, Murray-Lyon IM. High lipid parenteral feeds raise plasma branched chain amino acid concentrations-a possible therapeutic approach to portasystemic encephalopathy?. Clinical Nephrology 1986;5:109-12.
138. Grungreiff K, Kleine FD, Musil HE, Diete U, Franke D, Klauck S, et al. Valine enriched branched-chain amino acids in the treatment of hepatic encephalopathy Valin und Verzweigtkettige Aminosauren in der Behandlung der Hepatischen Enzephalopathie. Zeitschrift für Gastroenterologie 1993;314:235-41.
139. Grungreiff K, Lambert-Baumann J. Efficacy of L-ornithin-L- aspartate-granules in chronic liver diseases Wirksamkeit von L-ornithin-L-aspartat-granulat bei chronischen lebererkrankungen. Medizinische Welt 2001;527-8:219-26.
140. Guarnieri GF, Toigo G, Pozzato G, Faccini L, Giuntini D, Situlin R, et al. Long-term oral supplementation of chronic liver disease patients with branched-chain amino acids and/or energy Abstract. Clinical Nutrition 1982;1 Special Suppl:54.
141. Guarnieri GF, Toigo G, Situlin R, Pozzato G, Faccini L, et al. Muscle biopsy studies on malnutrition in patients with liver cirrhosis. In: Capocaccia L, Fischer JE, Rossi-Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:193-208.
142. Guarnieri GF, Chiesa L, Toigo G, Pozzato G, Lucchesi A, Sasso F, et al. Short-term treatment of chronic recurrent hepatic encephalopathy with enteral administration of a mixture rich in branched-chain amino acids and energy Trattamento a breve termine dell’encefalopatia epatica cronica ricorrente con somministrazione enterale di una miscela ricca in aminoacidi ramificati ed energia. Giornale di Clinica Medica 1984;652:79-85.
143. Habu D, Nishiguchi S. Effect of oral supplementation with branched-chain amino acid granules on serum albumin level in the early stage of cirrhosis Abstract. Journal of Parenteral and Enteral Nutrition 2003;271:37-8.
144. Habu D, Nishiguchi S, Nakatani S, Kawamura E, Lee C, Enomoto M, et al. Effect of oral supplementation with branched- chain amino acid granules on serum albumin level in the early stage of cirrhosis: A randomized pilot trial. Hepatology Research 2003;253:312-8.
145. Habu D, Nishiguchi S, Nakatani S, Lee C, Enomoto M, Tamori A, et al. Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis. Hepato- gastroenterology 2009;5696:1719-23.
146. Haji S, Shinzaki W, Satoi S, Ohlyanagi H. Immunonutrition with high-dose EPA and arginine induces immunological preconditioning on TH1/TH2 balance in major hepatic resection for liver malignancy Abstract. Clinical Nutrition 2008;Suppl 1:64.
147. Hayaishi S, Chung H, Kudo M, Ishikawa G, Takita M, Ueda T, et al. Oral Branched-Chain Amino Acid Granules Reduce the Incidence of Hepatocellular Carcinoma and Improve Event¬Free Survival in Patients With Liver Cirrhosis. Digestive Diseases 2011;293:326-32.
148. Hayashi M, Ikezawa K, Ono A, Okabayashi S, Hayashi Y, Shimizu S, et al. Evaluation of the effects of combination therapy with branched-chain amino acid and zinc supplements on nitrogen metabolism in liver cirrhosis. Hepatology Research 2007;378:615-9.
149. Herlong HF, Maddrey WC, Walser M. The use of ornithine salts of branched-chain ketoacids in portal-systemic encephalopathy. Annals of Internal Medicine 1980;934:545-50.
150. Hernandez-Guerra M, Garcia-Pagan JC, Turnes J, Bellot P, Deulofeu R, Abraldes JG, et al. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology 2006;433:485-91.
151. Holdsworth JD, Dionigi P, Clague MB, James OFW, Wright PD. Body protein metabolism and plasma amino acids in cirrhosis of the liver The effect of varying the branched chain amino acid content of intravenous amino acid solutions. Clinical Nutrition 1984;3:153-62.
152. Holm E, Langhans W, Meisinger E, Hiltmann W-D, Gastreiger P. BCAA-enriched diets for oral treatment of patients with liver cirrhosis: A controlled study of biochemical variables, psychometric performance, and the EEG Abstract. Journal of Parenteral and Enteral Nutrition 1981;5:354.
153. Holm E, Tschepe A, Staedt U, Leweling H, Striebel JP. Concentrations of energy yielding substrates and metabolites in the postabsorptive state and during parenteral nutrition lipid systems in patients with liver cirrhosis Abstract. Clinical Nutrition 1984;2Spec Suppl:O.66.
154. Holm E, Hess Y, Leweling H, Barth H-O, Hagmüller E. Ornithine aspartate OA promotes amino acid AA retention in the peripheral tissues of patients with liver cirrhosis A double-blind randomized crossover study Abstract. Journal of Parenteral and Enteral Nutrition 2000;151:368.
155. Horst D, Grace N, Conn HO, Schiff E, Schenker S, Viteri A, et al. A double-blind randomized comparison of dietary protein and an oral branched chain amino acid BCAA solution in cirrhotic patients with chronic portal-systemic encephalopathy PSE Abstract. Hepatology 1982;21:184.
156. Horst D, Grace N, Conn HO, Schiff E, Schenker S, Viteri A, et al. A double-blind randomized comparison of dietary protein and oral branched chain amino acid BCAA supplement in cirrhotic patients with chronic portal-systemic encephalopathy PSE Abstract. Hepatology 1981;1:518.
157. Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A, et al. Comparison of dietary protein with an oral, branched chain enriched amino acid supplement in chronic portal-systemic encephalopathy: A randomized controlled trial. Hepatology 1984;42:279-87.
158. Huisman E, Van Hoek B, Van Soest H, Van Nieuwkerk KC, Arends J, Siersema PD, et al. Preventive versus “on-Demand” nutritional support to maintain nutritional state and quality of life during antiviral therapy for hepatitis C: A randomized controlled trial. Hepatology 2011;54 Suppl 1:851A.
159. Hwang SJ, Chan CY, Wu JC, Lee SD, Huan YS, Tsai YT. A randomized controlled trial for the evaluation of the efficacy of branched chain amino acid-enriched amino acid solution in the treatment of patients with hepatic encephalopathy. Chinese Journal of Gastroenterology 1988;5:185-92.
160. Ichida T, Shibasaki K, Muto Y, Satoh S, Watanabe A, Ichida F. Clinical-study of an enteral branched-chain amino-acid solution in decompensated liver-cirrhosis with hepatic-encephalopathy. Nutrition 1995;112:238-44.
161. Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Ninomiya M, Uchiyama H, et al. Bacterial sepsis after living donor liver transplantation: The impact of early enteral nutrition. Journal of the American College of Surgeons 2012;214:288-95.
162. Ilan Y, Sobol T, Sasson O, Ashur Y, Berry EM. A balanced 5:1 carbohydrate:protein diet: A new method for supplementing protein to patients with chronic liver disease. Journal of Gastroenterology and Hepatology 2000;1512:1436-41.
163. Itou M, Kawaguchi T, Taniguchi E, Shiraishi S, Ibi R, Mutou M, et al. Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study. Molecular Medicine Reports 2009;26:983-7.
164. Itou M, Kawaguchi T, Taniguchi E, Oriishi T, Suetsugu T, Hano R, et al. Supplementation before endoscopic therapy for esophageal varices reduces mental stress in patients with liver cirrhosis. Hepato-Gastroenterology 2011;58107-108:814-8.
165. Jentschura D, Storz LW, Rumstadt B, Winkler M. Hepatic encephalopathy following porto-systemic shunt. Langenbecks Archiv Fur Chirurgie 1996;3815:283-8.
166. Jiang ZM, Gu ZY, Chen FL, Wang XR, Li ZJ, Xu Y, et al. The role of immune enhanced enteral nutrition on plasma amino acid, gut permeability and clinical outcome a randomized, double blind, controlled, multi-center clinical trail with 120 cases. Acta Academiae Medicinae Sinicae 2001;235:515-8.
167. Jiang H, Li B, Yan L-N, Lu S-C, Wen T-F, Zhao J-C, et al. Effect of intravenous glutamine-dipeptide fortified enteral nutrition on clinical outcomes in patients after liver transplantation: A prospective randomized controlled study. Chinese Jouirnal of Clinical Nutrition 2007;151:21-5.
168. Jonung T, Jeppsson B, Aslund U, Nair BM. A comparison between meat and vegan protein diet in patients with mild chronic hepatic encephalopathy. Clinical Nutrition 1987;63:169-74.
169. Kaido T, Mori A, Ogura Y, Hata K, Yoshizawa A, lida T, et al. Impact of enteral nutrition using a new immuno-modulating diet after liver transplantation. Hepato-Gastroenterology 2010;57104:1522-5.
170. Kakumitsu S, Shijo H, Yokoyama M, Kim T, Akiyoshi N, Ota K, et al. Effects of L-arginine on the systemic, mesenteric, and hepatic circulation in patients with cirrhosis. Hepatology 1998;272:377-82.
171. Kanematsu T, Koyanagi N, Matsumata T, Kitano S, Takenaka K, Sugimachi K. Lack of preventive effect of branched-chain amino acid solution on postoperative hepatic encephalopathy in patients with cirrhosis: A randomized, prospective trial. Surgery 1988;1043:482-8.
172. Kanematsu Takashi, et al. Is branched chain amino acid infusion effective in prevention of postoperative hepatic failure in patients with hepatic cirrhosis?: A prospective, randomized study Kankohen Shorei no Jutsugo Kanfuzen Yobo ni Bunkisa Aminosan BCAA Yueki wa Yuko ka?: Prostective, Randomized Study. Rinsho to Kenkyu The Japanese Journal of Clinical and Experimental Medicine 1988;653:897.
173. Katsumi N, Kawamura N, Yamaguchi Y, Sato Y, Morozumi K, Nakajima H, et al. Effect of oral branched chain amino acid- rich nutrient administered during endoscopic injection sclerotherapy of cirrhotic patients. Hepatology Research 2005;323:158-62.
174. Kawaguchi T, Taniguchi E, Itou M, Mutou M, Ibi R, Shiraishi S, et al. Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis. Hepatology Research 2008;3812:1178-85.
175. Kawamura E, Habu D, Iwai S, Morikawa H, Enomoto M, Tamori A, et al. A randomized pilot trial of oral branched-chain amino acids in early liver cirrhosis. Journal of Hepatology 2008;48 Suppl 2:116-7.
176. Kawamura E, Habu D, Morikawa H, Enomoto EM, Kawabe J, Tammori A, et al. A randomized pilot trial of oral branched- chain amino acids in early cirrhosis: Validation using prognostic markers for pre-liver transplant status. Liver Transplantation 2009;157:790-7. MEDLINE: 19562716
177. Keshavarzian A, Meek J, Sutton C, Emery VM, Hughes EA, Hodgson HJ. Dietary protein supplementation from vegetable sources in the management of chronic portal systemic encephalopathy. American Journal of Gastroenterology 1984;7912:945-9.
178. Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, et al. Therapeutic efficacy of L-ornithine-L- aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study. Hepatology 1997;256:1351-60.
179. Stauch S, Kircheis G, Adler G, Beckh K, Ditschuneit H, Gortelmeyer R, et al. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: Results of a placebo-controlled double-blind study. Journal of Hepatology 1998;285:856-64.
180. Kobayashi M, Ikeda K, Arase Y, Suzuki Y, Suzuki F, Akuta N, et al. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus. Journal of Gastroenterology 2008;431:63-70.
181. Krasnoff JB, Vintro AQ, Ascher NL, Bass NM, Paul SM, Dodd MJ, et al. A randomized trial of exercise and dietary counselling after liver transplantation. American Journal of Transplantation 2006;68:1896-905.
182. Kuroda H, Ushio A, Miyamoto Y, Sawara K, lokawa K, Kasai K, et al. Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: A one-year prospective trial. Journal of Gastroenterology and Hepatology 2010;25:1550-5.
183. Kuse ER, Kemnitz J, Kotzerke J, Wassmann R, Gubernatis G, Ringe B, et al. Fat emulsions in parenteral nutrition after liver transplantation: The recovery of the allografts RES function and histological observations. Clinical Nutrition 1990;96:331-6.
184. Kuse ER, Kotzerke J, Ringe B, Wassmann R, Gubernatis G, Pichlmayr I. Fat emulsions in parenteral feeding following liver transplantation I Effect on the recovery of RES function in the transplant Fettemulsionen in der parenteralen Ernahrung nach Lebertransplantation I Einfluss auf die Erholung der RES- Funktion im Transplantat. Annales Chirurgiae et Gynaecologiae 1990;256:428-31.
185. Kuse ER, Nordmann S, Kemnitz J, Gubernatis G, Kotzerke J. MCT/LCT-fat emulsions in the parenteral nutrition of patients after liver transplantation. Influence on the recovery of the RES function and the level of liver cell fatty degeneration MCT/LCT-Fettemulsionen in der parenteralen Ernahrung des lebertransplantierten Patienten. Einfluss auf die Erholung der RES-Funktion und den Grad der Leberzellverfettung.. Zeitschrift fur Gastroenterologie 1989;271:40.
186. Kuse ER, Kotzerke J, Muller S, Nashan B, Luck R, Jaeger K. Hepatic reticuloendotherlial function during parenteral nutrition including an MCT/LCT or LCT emulsion after liver transplantation? a double-blind study. Transplantation International 2002;15:272-7.
187. Müller S, Kotzerke J, Behrend M, Liebau P, Wu A, Kuse ER. Double-blind study on hepatic RES-function after hepatic transplantation under parenteral nutrition with an MCT- or LCT-lipid-emulsion Doppelblind-Studie zur hepatischen RES-Funktion nach Lebertransplantation unter parenteraler Ernährung mit einer MCT- oder LCT-Fettemulsion. Wiener Klinische Wochenschrift 1995; 107 Suppl 198:13-4.
188. Labadie M, Arnaud J, Enkaoua W, Zarski JP, Tricot F, Vaysse J, et al. Effect of zinc supplementation in alcoholic cirrhosis. A double blind, randomized study. Trace Elements in Medicine 1994;111:23-8.
189. Laterre P-F, Fleury Y. Safety and tolerance on lipids of parenteral and enteral nutrition in critically ill patients with liver failure. ClinicalTrials.gov NCT00522730.
190. Leon CDG. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial. Nutrition in Clinical Practice 2009;241:104-6.
191. Les I, Doval E, Garcia-Martinez R, Planas M, Cardenas G, Gomez P, et al. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: A randomized study. American Journal of Gastroenterology 2011;106:1081-8.
192. Les I, Planas M, Cardenas G, Flavia M, Vergara M, Soriano G, et al. Effects of the proteins of the diet in patients with cirrhosis and a prior episode of hepatic encephalopathy. A long-term randomized study. Hepatology 2009;50 Suppl4:313A.
193. Luntz SP, Unnebrink K, Seibert-Grafe M, Bunzendahl H, Kraus TW, Buchler MW, et al. HEGPOL: Randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation ISRCTN69350312. BMC Surgery 2005;5:18.
194. Mager DR, Wykes LJ, Roberts EA, Ball RO, Pencharz PB. Branched-chain amino acid needs in children with mild-to- moderate chronic cholestatic liver disease. Journal of Nutrition 2006;1361:133-9
195. Mager DR, Wykes LJ, Roberts EA, Ball RO, Pencharz PB. Effect of orthotopic liver transplantation OLT on branched-chain amino acid requirement. Pediatric Research 2006;596:829-34.
196. Makay B, Duman N, Ozer E, Kumral A, Yesilirmak D, Ozkan H. Randomized, controlled trial of early intravenous nutrition for prevention of neonatal jaundice in term and near-term neonates. Journal of Pediatric Gastroenterology and Nutrition 2007;443:354-8.
197. Malaguarnera M, Risino C, Cammalleri L, Malaguanera L, Astuto M, Vecchio I, et al. Branched chain amino acids supplemented with l-acetylcarnitine versus BCAA treatment in hepatic coma: A randomized and controlled double blind study. European Journal of Gastroenterology and Hepatology 2009;217:762-70. MEDLINE: 19357525
198. Mangiante G, Rossi L, Carluccio S, Marchiori L, Colucci G, Ciola M, et al. Influence of enteral nutrition on cytokine response in resective liver surgery Influenza della nutrizione enterale sulla risposta citochinica in chirurgia resettiva epatica. Chirurgia Italiana 2002;545:613-9.
199. Mangiante GL. Influence of enteral nutrition on cytokines response in resective liver surgery for HCC. International Journal of Cancer 2002;Suppl 13:235.
200. Manguso F, D’Ambra G, Menchise A, Sollazzo R, D’Agostino L. Effects of an appropriate oral diet on the nutritional status of patients with HCV-related liver cirrhosis: A prospective study. Clinical Nutrition 2005;245:751-9.
201. Marchesini G, Zoll M, Dondi C, Cecchini L, Angiolini A, Bianchi F, et al. Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance. Digestive Diseases and Sciences 1980;2510:763-8.
202. Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario E, Fabbri A, et al. Oral BCAA supplementation in cirrhosis with chronic encephalopathy: Effects on prolactin and estradiol levels. Hepatogastroenterology 1992;395:443-6.
203. Bianchi GP, Marchesini G, Zoli M, Bellati G, Colombo A, Ideol G, et al. Oral BCAA supplementation in patients with liver cirrhosis Preliminary results of a randomized double multicentre study Abstract. Italian Journal of Gastroenterology 1987;19:120.
204. Marchesini G, Bianchi GP, Zoli M, Bellati G, Colombo A, Ideo G, et al. A randomized double-blind study of oral BCAA in patients with cirrhosis Abstract. Journal of Hepatology 1987;5 Suppl 1:43.
205. Marchesini G, Dioguardi F.S, Bianchi G.P, Zoli M, Bellati G, Roffi L, et al. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. Journal of Hepatology 1990;111:92-101.
206. Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, et al. A randomized double-blind study of oral BCAA in patients with cirrhosis Abstract. Journal of Hepatology 1990;10 Suppl 1:15.
207. Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, et al. Nutritional supplementation with branched- chain amino acids in advanced cirrhosis: A double-blind, randomized trial. Gastroenterology 2003;1247:1792-801.
208. Marchini JS, Vannucchi H, Dutra de Oliveira JE. Effect of two carbohydrate:lipid ratios of diets enterally fed to chronic alcoholics. Human Nutrition: Clinical Nutrition 1983;37C:329-37.
209. Marra F, Riccardi D, Melani L, Spadoni S, Galli C, Fabrizio P, et al. Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation. Journal of Hepatology 1998;284:654-61.
210. McGhee A, Henderson JM, Millikan WJ Jr, Bleier JC, Vogel R, Kassouny M, et al. Comparison of the effects of Hepatic-Aid and a Casein modular diet on encephalopathy, plasma amino acids, and nitrogen balance in cirrhotic patients. Annals of Surgery 1983;1973:288-93.
211. Mendenhall C, Bongiovanni G, Goldberg S, et al. VA cooperative study on alcoholic hepatitis III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy. Journal of Parenteral & Enteral Nutrition 1985;95:590-6.
212. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: Results of a Department of Veterans Affairs cooperative study. Hepatology 1993;174:564-76.
213. Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, et al. Protein-energy malnutrition in severe alcoholic hepatitis-diagnosis and response to treatment. Journal of Parenteral and Enteral Nutrition 1995;194:258-65.
214. Morgan TR, Moritz TE, Mendenhall CL, Haas R. Protein consumption and hepatic encephalopathy in alcoholic hepatitis VA Cooperative Study Group #275. Journal of the American College of Nutrition 1995;142:152-8.
215. Mezey E, Caballeria J, Mitchell MC, Pares A, Herlong HF, Rodes J. Effect of parenteral amino-acid supplementation on short term and long-term outcomes in severe alcoholic hepatitis-a randomized controlled trial. Hepatology 1991;146:1090-6.
216. Michel H, Bories P, Aubin JP, Pomier-Layrargues G, Bauret P, Bellet-Herman H. Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 1985;55:282-9.
217. Michel H, Bories P, Nalet B, Mourrut C, Pierrugues R. Exclusive parenteral nutrition EPN in denutritive alcoholic cirrhotics Abstract. Journal of Hepatology 1985;1 Suppl 2:290.
218. Michel H, Pomier-Layrargues G, Duhamel O, Lacombe B, Cuilleet G, Bellet-Hermann H. Intravenous infusion of ordinary and modified amino-acid solutions in the management of hepatic encephalopathy controlled study, 30 patients AASLDabstract. Gastroenterology 1980;79:1038.
219. Michel H, Pomier-Layrargues G, Qubin JP, Bories P, Mirouze D, Bellet-Herman H. Treatment of hepatic encephalopathy by infusion of a modified amino acid solution: Results of a controlled study in 47 cirrhotic patients. In: Capocaccia L, Fischer JE, Rossi-Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:301-10.
220. Pomier-Layrargues G, Duhamel O, Lacombe B, Cuilleret G, Bellet H, Michel H. Intravenous infusion of ordinary and modified amino-acid solutions in the management of hepatic encephalopathy. Liver 1981;1:140.
221. Mochizuki H, Togo S, Tanaka K, Endo I, Shimada H. Early enteral nutrition after hepatectomy to prevent postoperative infection. Hepatogastroenterology 2000;47:1407-10.
222. Moreno C, Langlet P, Hittelet A, Evrard S, Lasser L, Colle I, et al. Enteral nutrition with or without n-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized, multicenter, controlled trial Abstract. Journal of Hepatology 2009;50 Suppl 1:366.
223. Moreno C, Langlet P, Hittelet A, Lasser L, Degre D, Evrard S, et al. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: A randomized multicenter controlled trial. Journal of Hepatology 2010;53:1117-22.
224. Morioka S, Kanai K, Kako M, Nakajima T, Yoshimi T, Masaka M, et al. Effects of branched chain amino acid infusion on glucose metabolism in cirrhotic patients with encephalopathy. Gastroenterologia Japonica 1983;186:553-9.
225. Muto Y, Yoshida T. Effect of oral supplementation with branched-chain amino acid granules on improvement of protein nutrition in decompensated liver cirrhosis: A cross¬over controlled study. In: Ogoshi S, Ikada A editors. Parenteral and Enteral Hyperalimentation. Amsterdam: Elsevier Science Publishers, 1984:280-92.
226. Muto Y, Yoshida T, Sato SI, Watanabe A, Okabe K. Effect of branched-chain amino acid granule BSAA-G on improvement in protein malnutrition in patients with liver cirrhosis: A multicentre double-blind trial Abstract. Journal of Gastroenterology and Hepatology 1991;63:312.
227. Moriwaki H, Muto Y, Sato S, Watanabe A, Suzuki K, Kato A, et al. Oral supplementation with branched chain amino acids reduces the incidence of liver failure in lean cirrhotic patients and prevents liver cancer in overweight/obese cirrhotics Abstract. Hepatology 2006;44 Suppl 14:216A.
228. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clinical Gastroenterology and Hepatology 2005;37:705-13.
229. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Long-term survival study LOTUS of branched-chain amino acid BCAA granules improves event-free survival in patients with advanced liver cirrhosis Abstract. Hepatology 2004;40 Suppl 44:511A.
230. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatology Research 2006;353:204-14.
231. Nagayama M, Takai T, Okuno M, Umeyama K. Fat emulsion in surgical patients with liver disorders. The Journal of Surgical Research 1989;471:59-64.
232. Nasrallah SM, Galambos JT. Aminoacid therapy of alcoholic hepatitis. Lancet 1980;28207:1276-7.
233. Ndraha S, Hasan I, Simadibrata M. The effect of L-ornithine L- aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta Medica Indonesiana 2011;431:18-22.
234. Nickkholgh A, Schneider H, Encke J, Buchler MW, Schmidt J, Schemmer P. PROUD: Effects of peroperative long-term immunonutritin in patients listed for liver transplantation. Trials 2007;8:20.
235. Nielsen K, Kondrup J, Martinsen L, Dossing H, Larsson B, Stilling B, et al. Long-term oral refeeding of patients with cirrhosis of the liver. British Journal of Nutrition 1995;744:557-67
236. Nishiguchi S, Habu D. Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis. Hepatology Research 2004;30 Suppl:36-41.
237. Nishizaki T, Takenaka K, Yanaga K, Shimada M, Shirabe K, Matsumata T, et al. Nutritional support after hepatic resection: A randomized prospective study. Hepatogastroenterology 1996;439:608-13.
238. Nordenstrom J, Johansson U, Thorne A, Hagenfeldt L. Metabolism of long-chain triglycerides LCT vs structured triglycerides STG in chronic liver failure Abstract. Clinical Nutrition 1995;14 Suppl 2:59.
239. O’Keefe SJ, Ogden J, Dicker J. Enteral and parenteral branched chain amino acid-supplemented nutritional support in patients with encephalopathy due to alcoholic liver disease. Journal of Parenteral and Enteral Nutrition 1987;115:447-53.
240. Okabayashi T, Nishimori I, Sugimoto T, Iwasaki S, Akisawa N, Maeda H, et al. The benefit of the supplementation of perioperative branched-chain amino acids in patients with surgical management for hepatocellular carcinoma: A preliminary study. Digestive Diseases and Sciences 2008;531:204-9.
241. Okabayashi T, Nishimori I, Sugimoto T, Maeda H, Dabanaka K, Onishi S, et al. Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008;2312:1869-73.
242. Okabayashi T, lyoki M, Sugimoto T, Kobayashi M, Hanazaki K. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids 2011;40:1213-20.
243. Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Namikawa T, Maeda H, et al. Preoperative oral supplementation with carbohydrate and branched-chain amino acid-enriched nutrient improves insulin resistance in patients undergoing a hepatectomy: A randomized clinical trial using an artificial pancreas. Amino Acids 2010;38:901-7. MEDLINE: 20852905
244. Okita M, Watanabe A, Nagashima H. A branched-chain amino acid-supplemented diet in the treatment of liver cirrhosis. Current Therapeutic Research 1984;351:83-92.
245. Okita M, Watanabe A, Nagashima H. Nutritional treatment of liver cirrhosis by branched-chain amino acid-enriched nutrient mixture. Journal of Nutrition Science and Vitaminology 1985;313:291-303.
246. Okuno M, Nagayama M, Takai T, Rai A, Nakao S, Kamino K, et al. Postoperative total parenteral nutrition in patients with liver disorders. Journal of Surgical Research 1985;392:93-102.
247. Olde Damink SWM, Jalan R, Deutz NEP, Dejong CHC, Redhead DN, Hynd P, et al. Isoleucine infusion during “simulated” upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients. Hepatology 2007;453:560-8.
248. Panella C, Guglielmi FW, Laddaga L, Rocco VP, Marcone I, Polimeno L, et al. Improvement of nitrogen balance in cirrhotic patients after oral BCAA Abstract. Journal of Hepatology 1987;5 Suppl 1:50.
249. Pierrugues R, Bauret P, Michel H. Continous enteral nutrition CEN in denutritive alcoholic cirrhotics randomized trial Abstract. Journal of Hepatology 1985;1 Suppl 2:308.
250. Plank LD, McCall JL, Gane EJ, Rafique M, Gillanders LK, McIlroy K, Munn SR. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: A pilot study of safety and efficacy. Clinical Nutrition 2005;242:288-96.
251. Plank LD, Gane EJ, Peng S, Muthu C, Mathur S, Gillanders L, et al. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12- month trial. Hepatology 2008;482:557-66.
252. Plauth M, Egberts EH, Hamster W, Török M, Müller P, Brand O, et al. Long-term treatment with branched-chain amino acids BCA improves the portosystemic encephalopathy PSE in ambulant patients Results of a double blind, placebo controlled crossover study Abstract Langzeitbehandlung mit verzweigtkettingen aminosauren verbessert die portosystemische enzephalopathie PSE ambulanter patienten Ergebnisse einer dobbelt-blinden plazebo-kontrollerten crossover studie. Klinische Wochenschrift 1992;69 Suppl 28:126.
253. Plauth M, Egberts EH, Hamster W, Török M, Müller PH, Brand O, et al. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double¬blind placebo-controlled crossover study. Journal of Hepatology 1993;173:308-14.
254. Protheroe S, Jones R, Kelly DA. Evaluation of the role of branched chain amino acids in the treatment of protein malnutrition in infants with liver disease Abstract. Gut 1995;37 Suppl 2:A30.
255. Protheroe S, McNurlan M, Garlick P, Golden M, Booth I, Kelly D. Faillure to suppress protein breakdown contributes towards malnutrition in infants with liver disease Abstract. Hepatology 1996;244 Pt 2:141A.
256. Puglionisi A, Ceriati F, Marino IR, Cavicchioni C, De Luca G, Roncone A, et al. Prophylaxis of hepatic encephalopathy after porta-caval anastomosis using branched chain amino acid mixtures. In: Capocaccia L, Fischer JE, Rossi-Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:345-50.
257. Rakette S, Fischer M, Reimann H-J, von Sommoggy S. Effects of special amino acid solutions in patients with liver cirrhosis and hepatic encephalopathy. In: Walser M, Williamson JR editors. Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Amsterdam: Elsevier North Holland, 1981:419-25.
258. Rayes N, Hansen S, Boucsein K, Seehofer D, Muller AR, Bengmark S, et al. Enteral nutrition containing lactobacillus versus selective gut decontamination after liver transplantation Laktobazillenhaltige enterale Ernahrung versus SDD nach Lebertransplantation. Zeitschrift fur Gastroenterologie 2002;402:119.
259. Rayes N, Hansen S, Muller AR, Staffa G, Bechstein WO, Neuhaus P. SBD versus fibre containing enteral nutrition plus Lactobacillus or placebo to prevent bacterial infections after liver transplantation. Transplantation 1999;677:747.
260. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002;741:123-7.
261. Rayes N, Seehofer D, Theruvath T, Langrehr JM, Muller AR, Bengmark S, et al. Impact of early enteral nutrition with a combination of pre- and probiotics in patients following liver transplantation on the incidence of postoperative bacterial infections-a randomised, double-blind trial. Liver Transplantation 2003;96:305.
262. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial. American Journal of Transplantation 2005;51:125-30.
263. Riederer P, Jellinger K, Kleinberger G, Weiser M. Oral and parenteral nutrition with L-valine: Mode of action. Nutrition and Metabolism 1980;24:209-17.
264. Rifai K, Ockenga J, Manns MP, Bischoff SC. Repreated administration of a vitamin preparation containing glycocholic acid in patients with hepatobiliary disease. Alimentary Pharmacology and Therapeutics 2006;239:337-45.
265. Riggio O, Canbgiano C, Cascino A, Merli M, Stortoni M, Rossi Fanelli F, et al. Long term dietary supplement with branched chain amino acids: A new approach in the prevention of hepatic encephalopathy: Results of a controlled study in cirrhotics with porto-caval anastomosis. In: Capocaccia L, Fischer JE, Rossi- Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:183-92.
266. Rocchi E, Cassanelli M, Gibertini P, Pietrangelo A, Casalgrandi G, Ventura E. Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis?. Journal of Parenteral and Enteral Nutrition 1985;94:447-51.
267. Rocchi E, Cassanelli M, Gibertini P, Pietrangelo A, Trenti T, Ventura E. Nutritional effects of branched chain amino acid alone and enriched parenteral solutions in liver cirrhosis Abstract. Clinical Nutrition 1984;2 Special Suppl:O.65.
268. Rocchi E, Gibertini P, Casanelli M, Pietrangelo A, Ventura E. Plasma amino acids and nitrogen balance in response to short term branched amino acid parenteral nutrition in liver cirrhosis. Medecine and Chirurgie Digestives 1984;13:185-92.
269. Rossi Fanelli F, Cangiano C, Capocaccia L, Cascino A, Ceci F, Muscaritoli M, et al. Use of branched chain amino acids for treating hepatic encephalopathy: Clinical experiences. Gut 1986;27 Suppl 1:111-5.
270. Rossi Fanelli F, Cangiano C, Cascino A, Merli M, Riggio O, Stortoni M, et al. Branched-chain amino acids in the treatment of severe hepatic encephalopathy. In: Capocaccia L, Fischer JE, Rossi-Fanelli F editors. Hepatic Encephalopathy in Chronic Liver Failure. New York: Plenum Press, 1984:335-44.
271. Rossi Fanelli F, Riggio O, Cangiano C, Cascino A, DeConciliis D, Merli M, et al. Branched-chain amino acids vs lactulose in the treatment of hepatic coma: A controlled study. Digestive Diseases and Sciences 1982;27:929-35.
272. Sakaida I, Tsuchiya M, Okamoto M, Terai S, Okita K. The effect of a late evening snack in patients with liver cirrhosis Abstract. Hepatology 2004;40:632A.
273. Sato S, Watanabe A, Muto Y, Suzuki K, Kato A, Moriwaki H, et al. Clinical comparison of branched-chain amino acid l-Leucine, l-Isoleucine, l-Valine granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis LIV-EN study. Hepatology Research 2005;314:232-40.
274. Schafer VK, Winther MB, Ukida M, Leweling H, Reiter HJ, Bode JC. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy CHE of patients with liver cirrhosis. Zeitschrift Gastroenterologie 1981;19:356-62.
275. Shirabe K, Matsumata T, Shimada M, Takenaka K, Kawahara N, Yamamoto K, et al. A comparison of parenteral hyperalimentation and early enteral feeding regarding systemic immunity after major hepatic resection-- the results of a randomized prospective study. Hepatogastroenterology 1997;4413:205-9.
276. Shirabe K, Yoshimatsu M, Motomura T, Takeishi K, Toshima T, Muto J, et al. Beneficial effects of supplementation with branched-chain amino acids on postoperative bacteremia in living donor liver transplant recipients. Liver Transplantation 2011;179:1073-80.
277. Sieg A, Walker S, Czygan P, Gärtner U, Lanzinger-Rossnagel G, Stiehl A, et al. Branched-chain amino acid-enriched elemental diet in patients with cirrhosis of the liver. A double blind crossover trial. Zeitschrift für Gastroenterologie 1983;2111:644-50.
278. Soriano G. Study of the benefit of exercise and aminoacid supplements in cirrhotic patients. ClinicalTrials.gov NCT01060813.
279. Strauss E, Dos Santos WR, Da Silva EC, Lacet CM, Capacci Mde LL, Bernardini AP. Treatment of hepatic encephalopathy: A randomized clinical trial comparing a branched chain enriched amino acid solution to oral neomycin. Nutritional Support Services 1986;67:18-21.
280. Strauss E, Santos WR, Cartapatti da Silva E, Lacet CM, Capacci MLL, Bernardini AP. A randomized controlled clinical trial for the evaluation of the efficacy of a enriched branched- chain amino-acid solution compared to neomycin in hepatic encephalopathy Abstract. Hepatology 1983;35:862.
281. Striebel JP, Holm E, Lutz H, Storz LW. Parenteral nutrition and coma therapy with amino acids in hepatic failure. Journal of Parenteral and Enteral Nutrition 1979;34:240-6.
282. Sugawara G, Ebata T, Yokoyama Y, Igami T, Takahashi Y, Nagino M. Perioperative nutritional support for biliary cancer surgery. HPB 2011;13 Suppl 3:226.
283. Suzuki K, Kato A, Iwai M. Branched-chain amino acid treatment in patients with liver cirrhosis. Hepatology Research 2004;30 Suppl:25-9.
284. Swart GR, Frenkel M, van den Berg JWO. Minimum protein requirements in advanced liver disease: A metabolic ward study of the effects of oral branched chain amino acids. In: Walser M, Williamson JR editors. Metabolism and Clinical Implications of Branched Chain Amino and Ketoacids. Amsterdam: Elsevier North Holland, 1981:427-32.
285. Swart GR, Zillikens MC, Van Vuure JK, Van den Berg JWO. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ Clinical Research Ed. 1989;2996709:1202-3.
286. Tai M-LS, Razlan H, Goh K-L, Taib SHM, Huzaini ATM, Rampal S, et al. Short-term nasogastric feeding for hospitalised Asian patients with liver cirrhosis. Hepatology International 2011;51:356.
287. Tai MLS, Mahadeva S. Short term feeding for Asian patients with liver cirrhosis. ClinicalTrials.gov NCT 01165073.
288. Tai MLS, Razlan H, Goh K-L, Mohd Taib SH, Huzaini AHM, Rampal S, et al. Short term nasogastric versus oral feeding in hospitalised patients with advanced cirrhosis: A randomised trial. e-SPEN 2011;66:e242-e247.
289. Tang Z-F, Ling Y-B, Hao Z, Lin N, Xu R-Y. Effects of glutamine and recombinant human growth hormone on intestinal mucosal barrier in postoperative portal hypertension patients. Chinese Journal of Clinical Nutrition 2006;145:296-9.
290. Tang ZF, Ling YB, Lin N, Hao Z, Xu RY. Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery. World Journal of Gastroenterology 2007;1315:2223-8.
291. Tayek JA. Treatment of alcoholic hepatitis with arginine. ClinicalTrials.gov NCT00200746.
292. Togo S, Tanaka K, Morioka D, Sugita M, Ueda M, Miura Y, et al. Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis. Nutrition 2005;214:480-6.
293. Tomiya T, Inoue Y, Yamaoka M, Hayashi S, Yanase M, Arai M, et al. Branched-chain amino acids may stimulate protein production by hepatocytes through the induction of hepatocyte growth factor synthesis by hepatic stellate cells Abstract. Hepatology 2002;364 Pt 2:320A.
294. Tschepe A, Holm E, Leweling H, Staedt U, Weber K. Oral administration of branched chain amino acids BCAA in patients with liver cirrhosis. A double-blind, randomized crossover study Abstract. Clinical Nutrition 1985;4 Special Suppl:40.
295. Tsuchiya K, Asahina Y, Hirayama I, Sato M, Tanaka T, Komatsu N, et al. Oral supplementation with branched-chain amino acids improves survival and recurrence-free survival after successful treatment of hepatocellular carcinoma in patients with cirrhosis: A prospective study. Hepatology 2007;46 Suppl 14:401A-2A.
296. Uribe M, Márquez MA, Garcia Ramos G, Ramos-Uribe MH, Vargas F, Villalobos A, et al. Treatment of chronic portal- systemic encephalopathy with vegetable and animal protein diets. A controlled crossover study. Digestive Diseases and Sciences 1982;2712:1109-16.
297. Valdivieso A, Morales H, Maiz A, Vial S. Effect of intravenous branched chain-enriched amino acids BCAAon renal function in patients with chronic liver disease CLD. Kidney International 1989;35:475.
298. Vilar Gomez E, Rodriguez De Miranda A, Gra Oramas B, Arus Soler E, Llanio Navarro R, Calzadilla Bertot L, et al. Clinical trial: A nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2009;3010:999-1009.
299. Gluud C, Dejgaard A, Hardt F, Kristensen, Kohler O, Melgaard B, et al. Preliminary treatment results with balanced amino acid infusion to patients with hepatic encephalopathy Abstract. Scandinavian Journal of Gastroenterology 1983;18 Suppl 86:19.
300. Hardt F, Dejgard A, Gluud C, Kristensen M, Kohler O, Melgaard B, et al. The effect of branched chain enriched amino acid nutrition on the outcome of acute hepatic coma in cirrhosis. The Copenhagen Coma Group Abstract. Clinical Nutrition 1985;4 Special Suppl:43.
301. Vilstrup H, Gluud C, Hardt F, Kristensen M, Kohler O, Melgaard B, et al. Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. Journal of Hepatology 1990;103:291-6.
302. Vilstrup H, Gluud C, Hardt F, Kristensen M, Melgaard B, Kohler O, et al. Branced chain enriched amino acid nutrition does not change the outcome of hepatic coma in patients with cirrhosis of the liver Abstract. Journal of Hepatology 1985;1 Suppl 2:347.
303. Wahren J, Denis J, Desurmont P, Eriksson LS, Escoffier JM, Gauthier AP, et al. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study. Hepatology 1983;34:475-80.
304. Wahren JH, Gauthier H, Michel P, Opolon H. Influence of branched-chain amino acid administration on hepatic encephalopathy- A multicenter study Abstract. Journal of Parenteral and Enteral Nutrition 1981;5:355.
305. Walker S, Gotz R, Czygan P, Stiehl A, Lanzinger G, Sieg A, et al. Oral keto analogs of branched-chain amino acids in hyperammonemia in patients with cirrhosis of the liver A double-blind crossover study. Digestion 1982;242:105-11.
306. Wang Y-L, Cao J-Y, Wu L-Q, Liu J-X. Effects of -3 fatty acids on inflammatory reaction and immunologic function of patients after hepatectomy. Chinese Journal of Clinical Nutrition 2011;193:162-6.
307. Watanabe A, Shiota T, Okita M, Nagashima H. Effect of a branched chain amino acid-enriched nutritional product on the pathophysiology of the liver and nutritional state of patients with liver cirrhosis. Acta Medica Okayama 1983;374:321-33.
308. Watanabe A, Kuwabara Y, Hioki O, Yago K, Kugu K, Akira M. Tentative diet for liver failure containing well-polished rice. Nutrition 1995;114:355-9.
309. Weber FL, Bagby BS, Licate L, Kelsen SG. Effects of branched- chain amino acids on nitrogen metabolism in patients with cirrhosis. Hepatology 1990;116:942-50.
310. Wicks C, Somasundaram S, Bjarnason I, Menzies IS, Routley D, Potter D, et al. Comparison of enteral feeding and total parenteral nutrition after liver transplantation. Lancet 1994;3448926:837-40.
311. Yamamoto M, Iwasa M, Matsumura K, Nakagawa Y, Fujita N, Kobayashi Y, et al. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World Journal of Gastroenterology 2005;1143:6792-9.
312. Yamanaka-Okumura H, Nakamura T, Miyake H, Takeuchi H, Katayama T, Morine Y, et al. Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatology Research 2010;405:470-6.
313. Yang J, Zhang J-X, Zheng Q-C. Olive oil-based lipid emulsion for parenteral nutrition in patients after hepatectomy. Chinese Journal of Clinical Nutrition 2011;192:79-83.
314. Yoshiji H, Noguchi R, Ikenaka Y, Kaji K, Aihara Y, Yamazaki M, et al. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: A randomized control trial. Oncology Reports 2011;266:1547-53.
315. Yu L-X, Liu Y-H, Shen Z-Y, Kang M-N. Prospective study of effect of recombinant human growth hormone on nutritional status and immune function in early postoperative stage of liver transplantation. Chinese Critical Care Medicine 2007;197:390-3.
316. Zhang T, Jia JD, Zhang FK, Wang BE. The effect of oral branched amino acid for cirrhotic patient with low serum protein. Chinese Journal of Clinical Hepatology 2003;192:84-5.
317. Zhang K, Sun WB, Wang HF, Li ZW, Zhang XD, Wang HB, et al. Early enteral and parenteral nutritional support in patients with cirrhotic portal hypertension after pericardial devascularization. Hepatobiliary & Pancreatic Diseases International 2005;41:55-9.
318. Zheng Q, Hu Q. The influence of enteral nutrition on gut barrier in the post-operative patients with damaged hepatic function. Journal of Tongji Medical University 2001;214:323-5.
319. Zhuang W, Wu X, Lü R, Xu H, Cao J. Pre-operation application of recombinant human growth hormone for liver cirrhosis with portal hypertension and hypoproteinemia. Sichuan daXueXue Bao. Yi Xue Ban Journal of Sichuan University. Medical science edition 2003;341:109-11.
320. Caballeria Rovira E, Arago Lopez JV, Ubeda Masso RM, Vidal Clemente JL, Sanchis Closa A. Treatment of hepatic encephalopathy with oral branched chain amino acids Tratamiento de la encefalopatia hepatica con aminoacidos de cadena ramificada BCAA por via oral: I. Encefalopatia hepatica aguda. Revista Española de Enfermedades Digestivas 1987;722:116-22.
321. Chen Q. Effects of early enteral nutrition on acute inflammatory response syndrome after the operations for obstructive jaundice. Hepatology International 2011;51:415.
322. Fink M, Mader R, Brauer HTI. Controlled double¬blind study on the effectiveness and tolerability of a combination therapy in chronic alcoholic liver diseases Kontrollierte Doppelblind-Studie auf Effektivitat und Vertraglichkeit einer Kombinationstherapie bei chronischen alkoholischen Lebererkrankungen. Fortschritte der Medizin 1978;9628:1428-32.
323. Hartung H-D. Aminoacid prevents hepatic encephalopathy Aminosauren verhindern hepatische Enzephalopathie. Fortschritte der Medizin 1989;107:56.
324. Khlynov IB, Chikunova MV, Lisovskaia TV. Effectiveness of nutritional support for the liver-cell deficiency in the liver cirrhosis. Experimental and Clinical Gastroenterology 2009;2:39-43. MEDLINE: PMID: 19552020
325. Korenaga M, Korenaga K, Nishina S, Tomiyama Y, Hino K. Oral branched-chain amino acid supplementation reduces oxidative stress and interacts with iron metabolism in patients with hepatitis C virus-related advanced liver fibrosis-A pilot study abstract. Hepatology 2011;54 Suppl 1:513A.
326. Leweling H, Knauff HG, Nitschke J, Paquet KJ. Effect of parenteral amino acid administration on the brain function and the serum aminogram of patients with liver cirrhosis Beeingflussung von zerebralem Funktionszustand und Serumaminogramm von Patienten mit Leberzirrhose durch parenterale Aminosaurenzufuhr. Infusionstherapie und Klinische Ernahrung 1980;7:88-94. MEDLINE: 6776054
327. Schafer K, Winther MB, Ukida M, Leweling H, Reiter HJ, Bode JC. Influence of an orally administered protein mixture enriched in branched chain amino acids on the chronic hepatic encephalopathy CHE of patients with liver cirrhosis. Zeitschrift fur Gastroenterologie 1981;197:356-62. MEDLINE: 7293293
328. Macias-Rosales R, Larrosa-Haro A. Efficacy of enteral vs. oral nutrition with a medium-chain triglyceride formula to prevent malnutrition and growth impairment in infants with biliary atresia. Journal Pediatric Gastroenterology and Nutrition 2011;51 Suppl 2:E22-3.
329. Zhu-ming J, Zhuo-yun G, Fu-lai C, Xiu-rong W, Ze-jian L, Yuan X, et al. The role of immune enhanced enteral nutrition on plasma amino acid, gut permeability and clinical outcome A randomized, double blind, controlled, multi-center clinical trial with 120 cases. Acta Academiae Medicinae Sinicae 2001;235:515-8.
330. Mao Y. A clinical study to evaluate the clinical outcomes of hepatectomy with nutritional risk after preoperative nutritional support. ClinicalTrials.gov NCT01292330.
331. Pirlich M. Enteral nutrition in liver cirrhosis. ClinicalTrials.gov NCT00168961.
332. Seguin P, Boudjema K, Malledant Y, Bellissant E. Effect of a perioperative oral nutritional supplementation on patients undergoing hepatic surgery for liver cancer IMPACT. ClinicalTrials.gov NCT00151671.
333. van Erpecum KJ. Nutritional support during antiviral therapy for hepatitis C. ClinicalTrials.gov NCT00841243
334. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boggo G, et al. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17:445-50.
335. Als-Nielsen B, Koretz RL, Gluud LL, Gluud C. Branched- chain amino acids for hepatic encephalopathy. Cochrane Database of Systematic Reviews 2003, Issue 1. DOI: 10.1002/14651858.CD001939
336. Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic patients. Nutrition 2005;21:113-7.
337. Baker JP, Detsky AS, Wesson DE, Wolman SL, Stewart S, Whitewall J, et al. Nutritional assessment. A comparison of clinical judgment and objective measurements. New England Journal of Medicine 1982;306:969-72.
338. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;618:763-9.
339. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;381:287-98.
340. Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. American Journal of Surgery 1980;139:160-7.
341. DeMets DL. Methods for combining randomized clinical trials: Strengths and limitations. Statistics in Medicine 1987;63:341-50.
342. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;73:177-88.
343. Dudrick SJ, Ruberg RL. Principles and practices of parenteral nutrition. Gastroenterology 1971;61:901-10.
344. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ Clinical Research Ed 1997;3157109:629-34.
345. Fischer JE, Baldessarini RJ. False neurotransmitters and hepatic failure. Lancet 1971;2:75-9. MEDLINE: 71235553
346. Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration Cochrane Review Groups CRGs. 2011, Issue 11. Art. No.: LIVER.
347. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;2111:1539-58.
348. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 updated March 2011. The Cochrane Colloboration, 2011. Available from www.cochrane-handbook.org.
349. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
350. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutritional status in cirrhosis. Journal of Hepatology 1994;21:317-25.
351. Jensen GL, Mirtallo J, Compher C, Dhaliwal R, Forbes A, Figueredo Grijalba R, et al. Adult starvation and disease-related malnutrition. A proposal for etiology-based diagnosis in the clinical practice setting from the International Consensus Guideline Committee. JPEN. Journal of Parenteral and Enteral Nutrition 2010; Vol. 34, issue 2:156-9.
352. Keys A. Caloric deficiency and starvation. In: Jolliffe N editors. Clinical Nutrition. 2nd Edition. New York: Harper and Brothers, 1962:122-36.
353. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135:982-9.
354. Kondrup J, Muller MJ. Energy and protein requirements of patients with chronic liver disease. Journal of Hepatology 1997;27:239-47